LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 23.10 | 84.90 | 51 | 1616 | 0.0316 | -0.1130 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 23.10 | 84.90 | 1137 | 1616 | 0.7035 | 0.8412 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 24.81 | 84.90 | 814 | 1769 | 0.4600 | 0.6752 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 24.81 | 84.90 | 934 | 1769 | 0.5278 | 0.7286 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 24.81 | 84.90 | 53 | 1769 | 0.0300 | -0.1020 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 24.81 | 84.90 | 1079 | 1769 | 0.6098 | 0.7865 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 26.51 | 84.90 | 830 | 1923 | 0.4316 | 0.6594 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 26.51 | 84.90 | 953 | 1923 | 0.4955 | 0.7112 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 26.51 | 84.90 | 60 | 1923 | 0.0312 | -0.0742 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 26.51 | 84.90 | 1169 | 1923 | 0.6079 | 0.7906 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 28.21 | 84.90 | 856 | 2091 | 0.4093 | 0.6485 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 28.21 | 84.90 | 984 | 2091 | 0.4705 | 0.6990 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 28.21 | 84.90 | 59 | 2091 | 0.0282 | -0.0757 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 28.21 | 84.90 | 1118 | 2091 | 0.5345 | 0.7466 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 29.92 | 84.90 | 873 | 2237 | 0.3901 | 0.6384 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 29.92 | 84.90 | 964 | 2237 | 0.4308 | 0.6732 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 29.92 | 84.90 | 58 | 2237 | 0.0259 | -0.0775 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 29.92 | 84.90 | 1127 | 2237 | 0.5036 | 0.7295 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 31.62 | 84.90 | 922 | 2449 | 0.3764 | 0.6351 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 31.62 | 84.90 | 1010 | 2449 | 0.4123 | 0.6661 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 31.62 | 84.90 | 66 | 2449 | 0.0269 | -0.0506 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 31.62 | 84.90 | 1148 | 2449 | 0.4686 | 0.7107 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 33.32 | 84.90 | 931 | 2722 | 0.3420 | 0.6139 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 33.32 | 84.90 | 1003 | 2722 | 0.3684 | 0.6381 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 33.32 | 84.90 | 74 | 2722 | 0.0272 | -0.0271 | MN20160318_Q02 | J22 |